Unknown

Dataset Information

0

Lung protection during non-invasive synchronized assist versus volume control in rabbits.


ABSTRACT: INTRODUCTION: Experimental work provides insight into potential lung protective strategies. The objective of this study was to evaluate markers of ventilator-induced lung injury after two different ventilation approaches: (1) a "conventional" lung-protective strategy (volume control (VC) with low tidal volume, positive end-expiratory pressure (PEEP) and paralysis), (2) a physiological approach with spontaneous breathing, permitting synchrony, variability and a liberated airway. For this, we used non-invasive Neurally Adjusted Ventilatory Assist (NIV-NAVA), with the hypothesis that liberation of upper airways and the ventilator's integration with lung protective reflexes would be equally lung protective. METHODS: In this controlled and randomized in vivo laboratory study, 25 adult White New Zealand rabbits were studied, including five non-ventilated control animals. The twenty animals with aspiration-induced lung injury were randomized to ventilation with either VC (6 mL/kg, PEEP 5 cm H2O, and paralysis) or NIV-NAVA for six hours (PEEP?=?zero because of leaks). Markers of lung function, lung injury, vital signs and ventilator parameters were assessed. RESULTS: At the end of six hours of ventilation (n?=?20), there were no significant differences between VC and NIV-NAVA for vital signs, PaO2/FiO2 ratio, lung wet-to-dry ratio and broncho-alveolar Interleukin 8 (Il-8). Plasma IL-8 was higher in VC (P <0.05). Lung injury score was lower for NIV-NAVA (P?=?0.03). Dynamic lung compliance recovered after six hours in NIV-NAVA but not in VC (P <0.05). During VC, peak pressures increased from 9.2?±?2.4 cm H2O (hour 1) to 12.3?±?12.3 cm H2O (hour 6) (P <0.05). During NIV-NAVA, the tracheal end-expiratory pressure was similar to the end-expiratory pressure during VC. Two animals regurgitated during NIV-NAVA, without clinical consequences, and survived the protocol. CONCLUSIONS: In experimental acute lung injury, NIV-NAVA is as lung-protective as VC 6 ml/kg with PEEP.

SUBMITTER: Mirabella L 

PROVIDER: S-EPMC4057206 | BioStudies | 2014-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC6682759 | BioStudies
2018-01-01 | S-EPMC6696998 | BioStudies
2019-01-01 | S-EPMC6800803 | BioStudies
2020-01-01 | S-EPMC7463691 | BioStudies
2014-01-01 | S-EPMC4350231 | BioStudies
2015-01-01 | S-EPMC7094250 | BioStudies
2020-01-01 | S-EPMC7327603 | BioStudies
1000-01-01 | S-EPMC3400991 | BioStudies
2016-01-01 | S-EPMC4872863 | BioStudies
2013-01-01 | S-EPMC3750001 | BioStudies